Repositioning From IV to Vial-Based SC for Large-Volume Biologics

Our expert discusses the growing trend of moving away from intravenous drugs administered in clinical and hospital settings to at-home, self-administered vial-based subcutaneous delivery for cost savings, better lifecycle management and improved care.

Learn more about our technology by reading the latest article in On Drug Delivery